Deborah Birx
Chief Executive Officer bei ARMATA PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Aktive Positionen von Deborah Birx
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Director/Board Member | 11.07.2023 | - |
| Chief Executive Officer | 11.07.2023 | - | |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Director/Board Member | - | - |
Karriereverlauf von Deborah Birx
Ehemalige bekannte Positionen von Deborah Birx
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 09.03.2021 | 10.07.2023 |
| Independent Dir/Board Member | 09.03.2021 | 10.07.2023 |
Ausbildung von Deborah Birx
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
- Börse
- Insiders
- Deborah Birx
- Erfahrung
